LCI earnings call for the period ending September 30, 2019.
News & Analysis: Lannett
It's getting hot in Beyond Meat's kitchen, while Lannett takes a big blast of bearishness.
Though major indexes rose, these companies got left behind.
The generic drug specialist raised money through a debt offering that might be a little more complicated than necessary.
The generic drug distributor ended its fiscal year riding a surge of momentum -- and shares have doubled in the last month.
The generic drug manufacturer announced fiscal 2019 results and inked an important supply deal.
LCI earnings call for the period ending June 30, 2019.
The generic-drug maker sailed past Wall Street revenue and earnings estimates and provided better-than-expected 2020 guidance.
The industry drew the ire of 44 state attorneys general alleging widespread conspiracy to inflate drug prices.
Forty-four states have brought a lawsuit against the industry.